Matter Bio

👥 12 employees💰 Last funded Feb 2022
Biotechnology Research🌐 matter.bio
Website LinkedIn
Matter Bio is a longevity holding company focused on preserving genome integrity As we age, our genome is constantly being damaged by exogenous and endogenous sources. Occasionally errors are missed and incorporated into the DNA in the form of mutations, structural variations, epigenetic drift, and other types of information loss. At Matter, we have assembled a world-class team of scientists and executives to help counter this critical information loss in the genome. To achieve this, we are focusing on a number of assets that address key stages in the genomic information loss continuum.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Antarctica
1
Frequently asked questions
Who invested in Matter Bio?
Matter Bio has 1 investors on record on gritt.io.
When did Matter Bio last raise funding?
The most recent investment in Matter Bio recorded on gritt.io was in February 2022.
What industry is Matter Bio in?
Matter Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.